{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:34Z","timestamp":1792036294973,"version":"4.4.0"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chair","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 111219"],"award-info":[{"award-number":["MOP 111219"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PDD 115217"],"award-info":[{"award-number":["PDD 115217"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates \u2013 Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.15252\/emmm.201707763","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T20:50:16Z","timestamp":1507582216000},"page":"1537-1557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Disease\u2010modifying effects of ganglioside GM1 in Huntington's disease models"],"prefix":"10.1038","volume":"9","author":[{"given":"Melanie","family":"Alpaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Galleguillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian W","family":"Lackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Di Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn G","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3060-0723","authenticated-orcid":false,"given":"Simonetta","family":"Sipione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"BFEMMM201707763_CR1","doi-asserted-by":"crossref","first-page":"e68584","DOI":"10.1371\/journal.pone.0068584","volume":"8","author":"YS Abada","year":"2013","unstructured":"Abada YS, Nguyen HP, Schreiber R, Ellenbroek B (2013) Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease. PLoS One 8: e68584","journal-title":"PLoS One"},{"key":"BFEMMM201707763_CR2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1749-6632.1998.tb09691.x","volume":"845","author":"M Alter","year":"1998","unstructured":"Alter M (1998) GM1 ganglioside for acute ischemic stroke. Trial design issues. Ann N Y Acad Sci 845: 391\u2013401","journal-title":"Ann N Y Acad Sci"},{"key":"BFEMMM201707763_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-0003-2-20","volume":"2","author":"I Amende","year":"2005","unstructured":"Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG (2005) Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehabil 2: 20","journal-title":"J Neuroeng Rehabil"},{"key":"BFEMMM201707763_CR4","first-page":"89","volume-title":"Handbook of physiology. Exercise: regulation and integration of multiple systems","author":"American Physiological Society","year":"1996","unstructured":"American Physiological Society (1996) Proprioceptive feedback and movement regulation. In Handbook of physiology. Exercise: regulation and integration of multiple systems, Rowell LB, Shepherd JT (eds), pp 89\u2013127. New York: American Physiological Society"},{"key":"BFEMMM201707763_CR5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nchembio.582","volume":"7","author":"RS Atwal","year":"2011","unstructured":"Atwal RS, Desmond CR, Caron N, Maiuri T, Xia J, Sipione S, Truant R (2011) Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol 7: 453\u2013460","journal-title":"Nat Chem Biol"},{"key":"BFEMMM201707763_CR6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA (2009) Increased hypothalamic\u2010pituitary\u2010adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab 94: 1223\u20131228","journal-title":"J Clin Endocrinol Metab"},{"key":"BFEMMM201707763_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.02.011","volume":"93","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N, Lieu C, Altshuler LL, Mintz J (2007a) Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res 93: 13\u201322.","journal-title":"Schizophr Res"},{"key":"BFEMMM201707763_CR8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","volume":"32","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S (2007b) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32: 1655\u20131664","journal-title":"Neurochem Res"},{"key":"BFEMMM201707763_CR9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/YCO.0000000000000140","volume":"28","author":"BT Baune","year":"2015","unstructured":"Baune BT (2015) Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention? Curr Opin Psychiatry 28: 148\u2013154","journal-title":"Curr Opin Psychiatry"},{"key":"BFEMMM201707763_CR10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/npp.2013.342","volume":"39","author":"C Belzung","year":"2014","unstructured":"Belzung C (2014) Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects? Neuropsychopharmacology 39: 1041\u20131051","journal-title":"Neuropsychopharmacology"},{"key":"BFEMMM201707763_CR11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1471-4159.1985.tb10529.x","volume":"45","author":"E Berry\u2010Kravis","year":"1985","unstructured":"Berry\u2010Kravis E, Dawson G (1985) Possible role of gangliosides in regulating an adenylate cyclase\u2010linked 5\u2010hydroxytryptamine (5\u2010HT1) receptor. J Neurochem 45: 1739\u20131747","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR12","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, Nairn AC, Messer A, Greengard P (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc Natl Acad Sci USA 97: 6809\u20136814","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201707763_CR13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbi.2006.10.005","volume":"21","author":"SD Bilbo","year":"2007","unstructured":"Bilbo SD, Newsum NJ, Sprunger DB, Watkins LR, Rudy JW, Maier SF (2007) Differential effects of neonatal handling on early life infection\u2010induced alterations in cognition in adulthood. Brain Behav Immun 21: 332\u2013342","journal-title":"Brain Behav Immun"},{"key":"BFEMMM201707763_CR14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D et\u00a0al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med 205: 1869\u20131877","journal-title":"J Exp Med"},{"key":"BFEMMM201707763_CR15","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","volume":"17","author":"FJ Bode","year":"2008","unstructured":"Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA, Bonin M, Nguyen HP, Riess O, Bauer A et\u00a0al (2008) Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta\u2010estradiol levels correlate with reduced numbers of DARPP32\u00a0+\u00a0 neurons in males. Hum Mol Genet 17: 2595\u20132609","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201707763_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nlm.2009.02.002","volume":"92","author":"VJ Bolivar","year":"2009","unstructured":"Bolivar VJ (2009) Intrasession and intersession habituation in mice: from inbred strain variability to linkage analysis. Neurobiol Learn Mem 92: 206\u2013214","journal-title":"Neurobiol Learn Mem"},{"key":"BFEMMM201707763_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","volume":"5","author":"JW Callahan","year":"2011","unstructured":"Callahan JW, Abercrombie ED (2011) In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6\/2) and Full\u2010Length (YAC128) Transgenic Mouse Models of Huntington's Disease. Front Syst Neurosci 5: 61","journal-title":"Front Syst Neurosci"},{"key":"BFEMMM201707763_CR18","doi-asserted-by":"crossref","first-page":"970204","DOI":"10.1155\/2015\/970204","volume":"2015","author":"J Casaca\u2010Carreira","year":"2015","unstructured":"Casaca\u2010Carreira J, Temel Y, van Zelst M, Jahanshahi A (2015) Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease. Behav Neurol 2015: 970204","journal-title":"Behav Neurol"},{"key":"BFEMMM201707763_CR19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0006-8993(97)01566-7","volume":"790","author":"ME Castro","year":"1998","unstructured":"Castro ME, Pascual J, Romon T, Berciano J, Figols J, Pazos A (1998) 5\u2010HT1B receptor binding in degenerative movement disorders. Brain Res 790: 323\u2013328","journal-title":"Brain Res"},{"key":"BFEMMM201707763_CR20","doi-asserted-by":"crossref","first-page":"e77023","DOI":"10.1371\/journal.pone.0077023","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, Volitakis I, Bush AI, Hersch S, Fox JH (2013a) Iron accumulates in Huntington's disease neurons: protection by deferoxamine. PLoS One 8: e77023","journal-title":"PLoS One"},{"key":"BFEMMM201707763_CR21","first-page":"114","volume":"7","author":"JY Chen","year":"2013","unstructured":"Chen JY, Wang EA, Cepeda C, Levine MS (2013b) Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front Neurosci 7: 114","journal-title":"Front Neurosci"},{"key":"BFEMMM201707763_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2013.11.046","volume":"260","author":"D Cheng","year":"2014","unstructured":"Cheng D, Low JK, Logge W, Garner B, Karl T (2014) Novel behavioural characteristics of female APPSwe\/PS1DeltaE9 double transgenic mice. Behav Brain Res 260: 111\u2013118","journal-title":"Behav Brain Res"},{"key":"BFEMMM201707763_CR23","doi-asserted-by":"crossref","first-page":"e1005043","DOI":"10.1371\/journal.pgen.1005043","volume":"11","author":"HM Cheng","year":"2015","unstructured":"Cheng HM, Chern Y, Chen IH, Liu CR, Li SH, Chun SJ, Rigo F, Bennett CF, Deng N, Feng Y et\u00a0al (2015) Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4\u00a0h knockdown. PLoS Genet 11: e1005043","journal-title":"PLoS Genet"},{"key":"BFEMMM201707763_CR24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","volume":"166","author":"S Chiavegatto","year":"2000","unstructured":"Chiavegatto S, Sun J, Nelson RJ, Schnaar RL (2000) A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice. Exp Neurol 166: 227\u2013234","journal-title":"Exp Neurol"},{"key":"BFEMMM201707763_CR25","doi-asserted-by":"crossref","unstructured":"Chinnock P, Roberts I (2005) Gangliosides for acute spinal cord injury. Cochrane Database Syst Rev CD004444","DOI":"10.1002\/14651858.CD004444.pub2"},{"key":"BFEMMM201707763_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2015.05.010","volume":"291","author":"A Ciamei","year":"2015","unstructured":"Ciamei A, Detloff PJ, Morton AJ (2015) Progression of behavioural despair in R6\/2 and Hdh knock\u2010in mouse models recapitulates depression in Huntington's disease. Behav Brain Res 291: 140\u2013146","journal-title":"Behav Brain Res"},{"key":"BFEMMM201707763_CR27","doi-asserted-by":"crossref","first-page":"e47240","DOI":"10.1371\/journal.pone.0047240","volume":"7","author":"WN Cong","year":"2012","unstructured":"Cong WN, Cai H, Wang R, Daimon CM, Maudsley S, Raber K, Canneva F, von Horsten S, Martin B (2012) Altered hypothalamic protein expression in a rat model of Huntington's disease. PLoS One 7: e47240","journal-title":"PLoS One"},{"key":"BFEMMM201707763_CR28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JHD-130077","volume":"2","author":"HE Crawford","year":"2013","unstructured":"Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, Landwehrmeyer B, Reilmann R, Craufurd D, Stout JC et\u00a0al (2013) Corpus callosal atrophy in premanifest and early Huntington's disease. J Huntingtons Dis 2: 517\u2013526","journal-title":"J Huntingtons Dis"},{"key":"BFEMMM201707763_CR29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","volume":"17","author":"JN Crawley","year":"2007","unstructured":"Crawley JN (2007) Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17: 448\u2013459","journal-title":"Brain Pathol"},{"key":"BFEMMM201707763_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE, Gosselin D, Lagier\u2010Tourenne C, Zuccato C, Cattaneo E, Gage FH, Cleveland DW, Glass CK (2014) Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage\u2010determining factors. Nat Neurosci 17: 513\u2013521","journal-title":"Nat Neurosci"},{"key":"BFEMMM201707763_CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"BFEMMM201707763_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","volume":"4","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discovery 4: 775\u2013790","journal-title":"Nat Rev Drug Discovery"},{"key":"BFEMMM201707763_CR33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547\u2013569","journal-title":"Neurosci Biobehav Rev"},{"key":"BFEMMM201707763_CR34","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","volume":"29","author":"DM Cummings","year":"2009","unstructured":"Cummings DM, Andre VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS (2009) Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci 29: 10371\u201310386","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR35","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s11064-017-2266-0","volume":"42","author":"R Dai","year":"2017","unstructured":"Dai R, Zhang S, Duan W, Wei R, Chen H, Cai W, Yang L, Wang Q (2017) Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Abeta1\u201042\u2010Induced Neurotoxicity and Cognitive Deficits. Neurochem Res 42: 2417\u20132426","journal-title":"Neurochem Res"},{"key":"BFEMMM201707763_CR36","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP et\u00a0al (2007) Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6: 2833\u20132840","journal-title":"J Proteome Res"},{"key":"BFEMMM201707763_CR37","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1162\/jocn_a_00252","volume":"24","author":"LC Dang","year":"2012","unstructured":"Dang LC, Donde A, Madison C, O'Neil JP, Jagust WJ (2012) Striatal dopamine influences the default mode network to affect shifting between object features. J Cogn Neurosci 24: 1960\u20131970","journal-title":"J Cogn Neurosci"},{"key":"BFEMMM201707763_CR38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","volume":"62","author":"DJ David","year":"2009","unstructured":"David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP et\u00a0al (2009) Neurogenesis\u2010dependent and \u2010independent effects of fluoxetine in an animal model of anxiety\/depression. Neuron 62: 479\u2013493","journal-title":"Neuron"},{"key":"BFEMMM201707763_CR39","first-page":"e2607","volume":"59","author":"R Deacon","year":"2012","unstructured":"Deacon R (2012) Assessing burrowing, nest construction, and hoarding in mice. J Vis Exp 59: e2607","journal-title":"J Vis Exp"},{"key":"BFEMMM201707763_CR40","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/mds.22125","volume":"23","author":"A Delval","year":"2008","unstructured":"Delval A, Krystkowiak P, Delliaux M, Blatt JL, Derambure P, Destee A, Defebvre L (2008a) Effect of external cueing on gait in Huntington's disease. Mov Disord 23: 1446\u20131452","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.21896","volume":"23","author":"A Delval","year":"2008","unstructured":"Delval A, Krystkowiak P, Delliaux M, Dujardin K, Blatt JL, Destee A, Derambure P, Defebvre L (2008b) Role of attentional resources on gait performance in Huntington's disease. Mov Disord 23: 684\u2013689","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","volume":"115","author":"CA Denny","year":"2010","unstructured":"Denny CA, Desplats PA, Thomas EA, Seyfried TN (2010) Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington's disease. J Neurochem 115: 748\u2013758","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","volume":"27","author":"PA Desplats","year":"2007","unstructured":"Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR, Sutcliffe JG, Seyfried TN, Thomas EA (2007) Glycolipid and ganglioside metabolism imbalances in Huntington's disease. Neurobiol Dis 27: 265\u2013277","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201707763_CR44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121: 66\u201372","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR45","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","volume":"109","author":"A Di Pardo","year":"2012","unstructured":"Di Pardo A, Maglione V, Alpaugh M, Horkey M, Atwal RS, Sassone J, Ciammola A, Steffan JS, Fouad K, Truant R et\u00a0al (2012) Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci USA 109: 3528\u20133533","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201707763_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.48727b68b39b82d5fe350f753984bcf9","author":"L Dodds","year":"2014","unstructured":"Dodds L, Chen J, Berggren K, Fox J (2014) Characterization of Striatal Neuronal Loss and Atrophy in the R6\/2 Mouse Model of Huntington's Disease. PLOS Currents Huntington Disease https:\/\/doi.org\/10.1371\/currents.hd.48727b68b39b82d5fe350f753984bcf9","journal-title":"PLOS Currents Huntington Disease"},{"key":"BFEMMM201707763_CR47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuroimage.2009.03.044","volume":"46","author":"G Douaud","year":"2009","unstructured":"Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P et\u00a0al (2009) In vivo evidence for the selective subcortical degeneration in Huntington's disease. NeuroImage 46: 958\u2013966","journal-title":"NeuroImage"},{"key":"BFEMMM201707763_CR48","first-page":"81","volume":"4","author":"X Du","year":"2013","unstructured":"Du X, Pang TY, Hannan AJ (2013) A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation. Front Neurol 4: 81","journal-title":"Front Neurol"},{"key":"BFEMMM201707763_CR49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","volume":"9","author":"ME Ehrlich","year":"2012","unstructured":"Ehrlich ME (2012) Huntington's disease and the striatal medium spiny neuron: cell\u2010autonomous and non\u2010cell\u2010autonomous mechanisms of disease. Neurotherapeutics 9: 270\u2013284","journal-title":"Neurotherapeutics"},{"key":"BFEMMM201707763_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fncir.2013.00019","volume":"7","author":"AM Estrada\u2010Sanchez","year":"2013","unstructured":"Estrada\u2010Sanchez AM, Rebec GV (2013) Role of cerebral cortex in the neuropathology of Huntington's disease. Front Neural Circuits 7: 19","journal-title":"Front Neural Circuits"},{"key":"BFEMMM201707763_CR51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/brb3.41","volume":"2","author":"M Faizi","year":"2012","unstructured":"Faizi M, Bader PL, Saw N, Nguyen TV, Beraki S, Wyss\u2010Coray T, Longo FM, Shamloo M (2012) Thy1\u2010hAPP(Lond\/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav 2: 142\u2013154","journal-title":"Brain Behav"},{"key":"BFEMMM201707763_CR52","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini J, Barrantes FJ (2009) Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 1788: 2345\u20132361","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201707763_CR53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40120-012-0005-7","volume":"1","author":"JM Ferrara","year":"2012","unstructured":"Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J (2012) Effect of tetrabenazine on motor function in patients with huntington disease. Neurol Ther 1: 5","journal-title":"Neurol Ther"},{"key":"BFEMMM201707763_CR54","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild\u2010type human alpha\u2010synuclein. J Neurosci 24: 9434\u20139440","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/15548627.2016.1160971","volume":"12","author":"T Garofalo","year":"2016","unstructured":"Garofalo T, Matarrese P, Manganelli V, Marconi M, Tinari A, Gambardella L, Faggioni A, Misasi R, Sorice M, Malorni W (2016) Evidence for the involvement of lipid rafts localized at the ER\u2010mitochondria associated membranes in autophagosome formation. Autophagy 12: 917\u2013935","journal-title":"Autophagy"},{"key":"BFEMMM201707763_CR56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","volume":"58","author":"MC Garrett","year":"1992","unstructured":"Garrett MC, Soares\u2010da\u2010Silva P (1992) Increased cerebrospinal fluid dopamine and 3,4\u2010dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission. J Neurochem 58: 101\u2013106","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(76)91024-6","volume":"106","author":"MA Geyer","year":"1976","unstructured":"Geyer MA, Puerto A, Menkes DB, Segal DS, Mandell AJ (1976) Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res 106: 257\u2013269","journal-title":"Brain Res"},{"key":"BFEMMM201707763_CR58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj2370147","volume":"237","author":"R Ghidoni","year":"1986","unstructured":"Ghidoni R, Trinchera M, Venerando B, Fiorilli A, Sonnino S, Tettamanti G (1986) Incorporation and metabolism of exogenous GM1 ganglioside in rat liver. Biochem J 237: 147\u2013155","journal-title":"Biochem J"},{"key":"BFEMMM201707763_CR59","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1371\/journal.pone.0013417","volume":"5","author":"C Giampa","year":"2010","unstructured":"Giampa C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, Fusco FR (2010) Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease. PLoS One 5: e13417","journal-title":"PLoS One"},{"key":"BFEMMM201707763_CR60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0014-4886(03)00223-1","volume":"183","author":"VM Goettl","year":"2003","unstructured":"Goettl VM, Zhang H, Burrows AC, Wemlinger TA, Neff NH, Hadjiconstantinou M (2003) GM1 enhances dopaminergic markers in the brain of aged rats. Exp Neurol 183: 665\u2013672","journal-title":"Exp Neurol"},{"key":"BFEMMM201707763_CR61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jchromb.2006.07.022","volume":"844","author":"SL Grant","year":"2006","unstructured":"Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB (2006) Determination of d\u2010serine and related neuroactive amino acids in human plasma by high\u2010performance liquid chromatography with fluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci 844: 278\u2013282","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFEMMM201707763_CR62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","volume":"23","author":"P Greengard","year":"1999","unstructured":"Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP\u201032\/protein phosphatase\u20101 cascade. Neuron 23: 435\u2013447","journal-title":"Neuron"},{"key":"BFEMMM201707763_CR63","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0006-3223(00)01041-6","volume":"48","author":"C Gross","year":"2000","unstructured":"Gross C, Santarelli L, Brunner D, Zhuang X, Hen R (2000) Altered fear circuits in 5\u2010HT(1A) receptor KO mice. Biol Psychiat 48: 1157\u20131163","journal-title":"Biol Psychiat"},{"key":"BFEMMM201707763_CR64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Group THsDCR","year":"1993","unstructured":"Group THsDCR (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971\u2013983","journal-title":"Cell"},{"key":"BFEMMM201707763_CR65","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I et\u00a0al (2005) Pathological cell\u2010cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46: 433\u2013444","journal-title":"Neuron"},{"key":"BFEMMM201707763_CR66","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW (2009) Serines 13 and 16 are critical determinants of full\u2010length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 64: 828\u2013840","journal-title":"Neuron"},{"key":"BFEMMM201707763_CR67","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s11064-008-9745-2","volume":"33","author":"F Hajos","year":"2008","unstructured":"Hajos F (2008) Changes in glial fibrillary acidic protein (GFAP) immunoreactivity reflect neuronal states. Neurochem Res 33: 1643\u20131650","journal-title":"Neurochem Res"},{"key":"BFEMMM201707763_CR68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK (2010) Simple combinations of lineage\u2010determining\u00a0transcription factors prime cis\u2010regulatory elements required\u00a0for macrophage and B cell identities. Mol Cell 38: 576\u2013589","journal-title":"Mol Cell"},{"key":"BFEMMM201707763_CR69","first-page":"167","volume":"167","author":"CC Henery","year":"1989","unstructured":"Henery CC, Mayhew TM (1989) The cerebrum and cerebellum of the fixed human brain: efficient and unbiased estimates of volumes and cortical surface areas. J Anat 167: 167\u2013180","journal-title":"J Anat"},{"key":"BFEMMM201707763_CR70","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3565(25)24362-2","volume":"238","author":"EJ Hess","year":"1986","unstructured":"Hess EJ, Albers LJ, Le H, Creese I (1986) Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. J Pharmacol Exp Ther 238: 846\u2013854","journal-title":"J Pharmacol Exp Ther"},{"key":"BFEMMM201707763_CR71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","volume":"81","author":"MA Hickey","year":"2002","unstructured":"Hickey MA, Reynolds GP, Morton AJ (2002) The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease. J Neurochem 81: 46\u201359","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-7-12","volume":"7","author":"MA Hickey","year":"2012","unstructured":"Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS et\u00a0al (2012) Improvement of neuropathology and transcriptional deficits in CAG 140 knock\u2010in mice supports a beneficial effect of dietary curcumin in Huntington's disease. Mol Neurodegener 7: 12","journal-title":"Mol Neurodegener"},{"key":"BFEMMM201707763_CR73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"ICM Hoogland","year":"2015","unstructured":"Hoogland ICM, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D (2015) Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation 12: 114","journal-title":"J Neuroinflammation"},{"key":"BFEMMM201707763_CR74","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1476-5381.2009.00563.x","volume":"159","author":"J Hwang","year":"2010","unstructured":"Hwang J, Lee S, Lee JT, Kwon TK, Kim DR, Kim H, Park HC, Suk K (2010) Gangliosides induce autophagic cell death in astrocytes. Br J Pharmacol 159: 586\u2013603","journal-title":"Br J Pharmacol"},{"key":"BFEMMM201707763_CR75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR et\u00a0al (2008) Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412: 191\u2013209","journal-title":"Biochem J"},{"key":"BFEMMM201707763_CR76","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/mds.21620","volume":"22","author":"R Jech","year":"2007","unstructured":"Jech R, Klempir J, Vymazal J, Zidovska J, Klempirova O, Ruzicka E, Roth J (2007) Variation of selective gray and white matter atrophy in Huntington's disease. Mov Disord 22: 1783\u20131789","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR77","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","volume":"97","author":"MA Johnson","year":"2006","unstructured":"Johnson MA, Rajan V, Miller CE, Wightman RM (2006) Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease. J Neurochem 97: 737\u2013746","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR78","doi-asserted-by":"crossref","first-page":"20026","DOI":"10.1074\/jbc.M109218200","volume":"277","author":"H Kanazawa","year":"2002","unstructured":"Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y (2002) Macrophage\/microglia\u2010specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C\u2010gamma \u2010dependent pathway. J Biol Chem 277: 20026\u201320032","journal-title":"J Biol Chem"},{"key":"BFEMMM201707763_CR79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jns.2014.09.053","volume":"347","author":"DA Kegelmeyer","year":"2014","unstructured":"Kegelmeyer DA, Kloos AD, Fritz NE, Fiumedora MM, White SE, Kostyk SK (2014) Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease. J Neurol Sci 347: 219\u2013223","journal-title":"J Neurol Sci"},{"key":"BFEMMM201707763_CR80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Holscher C et\u00a0al (2013) Microglia emerge from erythromyeloid precursors via Pu.1\u2010 and Irf8\u2010dependent pathways. Nat Neurosci 16: 273\u2013280","journal-title":"Nat Neurosci"},{"key":"BFEMMM201707763_CR81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2818.1984.tb00501.x","volume":"134","author":"JA Kiernan","year":"1984","unstructured":"Kiernan JA (1984) Chromoxane cyanine R. II. Staining of animal tissues by the dye and its iron complexes. J Microsc 134: 25\u201339","journal-title":"J Microsc"},{"key":"BFEMMM201707763_CR82","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.26014","volume":"29","author":"A Killoran","year":"2014","unstructured":"Killoran A, Biglan KM (2014) Current therapeutic options for Huntington's disease: good clinical practice versus evidence\u2010based approaches? Mov Disord 29: 1404\u20131413","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.physbeh.2008.07.031","volume":"95","author":"AM Kinn","year":"2008","unstructured":"Kinn AM, Gronli J, Fiske E, Kuipers S, Ursin R, Murison R, Portas CM (2008) A double exposure to social defeat induces sub\u2010chronic effects on sleep and open field behaviour in rats. Physiol Behav 95: 553\u2013561","journal-title":"Physiol Behav"},{"key":"BFEMMM201707763_CR84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","volume":"22","author":"SJ Kish","year":"1987","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1987) Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Ann Neurol 22: 386\u2013389","journal-title":"Ann Neurol"},{"key":"BFEMMM201707763_CR85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0028-3932(91)90085-M","volume":"29","author":"D Knopman","year":"1991","unstructured":"Knopman D, Nissen MJ (1991) Procedural learning is impaired in Huntington's disease: evidence from the serial reaction time task. Neuropsychologia 29: 245\u2013254","journal-title":"Neuropsychologia"},{"key":"BFEMMM201707763_CR86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00496859","volume":"48","author":"L Kokkinidis","year":"1976","unstructured":"Kokkinidis L, Anisman H (1976) Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task. Psychopharmacology 48: 261\u2013270","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00439098","volume":"52","author":"L Kokkinidis","year":"1977","unstructured":"Kokkinidis L, Anisman H (1977) Perseveration and rotational behavior elicited by d\u2010amphetamine in a Y\u2010maze exploratory task: differential effects of intraperitoneal and unilateral intraventricular administration. Psychopharmacology 52: 123\u2013128","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0091-3057(87)90160-2","volume":"26","author":"L Kokkinidis","year":"1987","unstructured":"Kokkinidis L (1987) Amphetamine\u2010elicited perseverative and rotational behavior: evaluation of directional preference. Pharmacol Biochem Behav 26: 527\u2013532","journal-title":"Pharmacol Biochem Behav"},{"key":"BFEMMM201707763_CR89","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS et\u00a0al (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 74: 1031\u20131044","journal-title":"Neuron"},{"key":"BFEMMM201707763_CR90","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan W, Trager U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C et\u00a0al (2012) Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Invest 122: 4737\u20134747","journal-title":"J Clin Invest"},{"key":"BFEMMM201707763_CR91","doi-asserted-by":"crossref","first-page":"e00104","DOI":"10.1002\/prp2.104","volume":"3","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Precious SV, Denovan\u2010Wright EM (2015) Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets. Pharmacol Res Perspect 3: e00104","journal-title":"Pharmacol Res Perspect"},{"key":"BFEMMM201707763_CR92","doi-asserted-by":"crossref","first-page":"51770","DOI":"10.1074\/jbc.M306767200","volume":"278","author":"E Laurine","year":"2003","unstructured":"Laurine E, Gregoire C, Fandrich M, Engemann S, Marchal S, Thion L, Mohr M, Monsarrat B, Michel B, Dobson CM et\u00a0al (2003) Lithostathine quadruple\u2010helical filaments form proteinase K\u2010resistant deposits in Creutzfeldt\u2010Jakob disease. J Biol Chem 278: 51770\u201351778","journal-title":"J Biol Chem"},{"issue":"Pt. 5","key":"BFEMMM201707763_CR93","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"AD Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington's disease. Brain 119(Pt. 5): 1633\u20131645.","journal-title":"Brain"},{"issue":"Pt. 7","key":"BFEMMM201707763_CR94","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","volume":"123","author":"AD Lawrence","year":"2000","unstructured":"Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW (2000) Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 123(Pt. 7): 1349\u20131364.","journal-title":"Brain"},{"key":"BFEMMM201707763_CR95","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1523\/JNEUROSCI.23-36-11411.2003","volume":"23","author":"H Leblond","year":"2003","unstructured":"Leblond H, L'Esperance M, Orsal D, Rossignol S (2003) Treadmill locomotion in the intact and spinal mouse. J Neurosci 23: 11411\u201311419","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tibs.2015.04.005","volume":"40","author":"RW Ledeen","year":"2015","unstructured":"Ledeen RW, Wu G (2015) The multi\u2010tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci 40: 407\u2013418","journal-title":"Trends Biochem Sci"},{"key":"BFEMMM201707763_CR97","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neubiorev.2006.03.006","volume":"30","author":"MP Leussis","year":"2006","unstructured":"Leussis MP, Bolivar VJ (2006) Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30: 1045\u20131064","journal-title":"Neurosci Biobehav Rev"},{"key":"BFEMMM201707763_CR98","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li JY, Popovic N, Brundin P (2005) The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx: the journal of the American Society for Experimental. Neurotherapeutics 2: 447\u2013464","journal-title":"Neurotherapeutics"},{"key":"BFEMMM201707763_CR99","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 19: 10428\u201310437","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR100","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","volume":"10","author":"CS Lobsiger","year":"2007","unstructured":"Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non\u2010cell\u2010autonomous neurodegenerative disease. Nat Neurosci 10: 1355\u20131360","journal-title":"Nat Neurosci"},{"key":"BFEMMM201707763_CR101","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","volume":"30","author":"V Maglione","year":"2010","unstructured":"Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, Sipione S (2010) Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1. J Neurosci 30: 4072\u20134080","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR102","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW et\u00a0al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493\u2013506","journal-title":"Cell"},{"key":"BFEMMM201707763_CR103","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0005-2736(89)90298-8","volume":"984","author":"NS Matinyan","year":"1989","unstructured":"Matinyan NS, Melikyan GB, Arakelyan VB, Kocharov SL, Prokazova NV, Avakian TM (1989) Interaction of ganglioside\u2010containing planar bilayers with serotonin and inorganic cations. Biochem Biophys Acta 984: 313\u2013318","journal-title":"Biochem Biophys Acta"},{"key":"BFEMMM201707763_CR104","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/hbm.22835","volume":"36","author":"JT Matsui","year":"2015","unstructured":"Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS, Investigators P\u2010H, Coordinators of the Huntington Study G (2015) Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp 36: 3717\u20133732","journal-title":"Hum Brain Mapp"},{"key":"BFEMMM201707763_CR105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF (2003) Time course of early motor and neuropathological anomalies in a knock\u2010in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol 465: 11\u201326","journal-title":"J Comp Neurol"},{"key":"BFEMMM201707763_CR106","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0270(02)00012-2","volume":"115","author":"GA Metz","year":"2002","unstructured":"Metz GA, Whishaw IQ (2002) Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore\u2010 and hindlimb stepping, placing, and co\u2010ordination. J Neurosci Methods 115: 169\u2013179","journal-title":"J Neurosci Methods"},{"key":"BFEMMM201707763_CR107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","volume":"93","author":"J Middeldorp","year":"2011","unstructured":"Middeldorp J, Hol EM (2011) GFAP in health and disease. Prog Neurobiol 93: 421\u2013443","journal-title":"Prog Neurobiol"},{"key":"BFEMMM201707763_CR108","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","volume":"62","author":"I Mocchetti","year":"2005","unstructured":"Mocchetti I (2005) Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci 62: 2283\u20132294","journal-title":"Cell Mol Life Sci"},{"key":"BFEMMM201707763_CR109","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.25980","volume":"29","author":"CD Moulton","year":"2014","unstructured":"Moulton CD, Hopkins CW, Bevan\u2010Jones WR (2014) Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease. Mov Disord 29: 1556\u20131561","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","volume":"3","author":"SS Moy","year":"2004","unstructured":"Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic\u2010like behavior in mice. Genes Brain Behav 3: 287\u2013302","journal-title":"Genes Brain Behav"},{"key":"BFEMMM201707763_CR111","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0092-8674(94)90066-3","volume":"79","author":"U Muller","year":"1994","unstructured":"Muller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rulicke T, Brandner S, Aguzzi A, Weissmann C (1994) Behavioral and anatomical deficits in mice homozygous for a modified beta\u2010amyloid precursor protein gene. Cell 79: 755\u2013765","journal-title":"Cell"},{"key":"BFEMMM201707763_CR112","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR (2014) Iron dysregulation in Huntington's disease. J Neurochem 130: 328\u2013350","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR113","first-page":"Unit 5.65","volume":"Chapter 5","author":"M Nollet","year":"2013","unstructured":"Nollet M, Le Guisquet AM, Belzung C (2013) Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol Chapter 5: Unit 5.65","journal-title":"Curr Protoc Pharmacol"},{"key":"BFEMMM201707763_CR114","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cortex.2013.11.009","volume":"52","author":"MJ Novak","year":"2014","unstructured":"Novak MJ, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ (2014) White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex 52: 98\u2013112","journal-title":"Cortex"},{"key":"BFEMMM201707763_CR115","doi-asserted-by":"crossref","first-page":"873860","DOI":"10.1155\/2015\/873860","volume":"2015","author":"M Olejniczak","year":"2015","unstructured":"Olejniczak M, Urbanek MO, Krzyzosiak WJ (2015) The Role of the Immune System in Triplet Repeat Expansion Diseases. Mediators Inflamm 2015: 873860","journal-title":"Mediators Inflamm"},{"key":"BFEMMM201707763_CR116","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-014-8974-4","volume":"52","author":"J Ooi","year":"2014","unstructured":"Ooi J, Hayden MR, Pouladi MA (2014) Inhibition of Excessive Monoamine Oxidase A\/B Activity Protects Against Stress\u2010induced Neuronal Death in Huntington Disease. Mol Neurobiol 52: 1850\u20131861","journal-title":"Mol Neurobiol"},{"key":"BFEMMM201707763_CR117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.890040304","volume":"4","author":"MJ Owens","year":"1989","unstructured":"Owens MJ, Bissette G, Nemeroff CB (1989) Acute effects of alprazolam and adinazolam on the concentrations of corticotropin\u2010releasing factor in the rat brain. Synapse 4: 196\u2013202","journal-title":"Synapse"},{"key":"BFEMMM201707763_CR118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25801","volume":"29","author":"JM Padowski","year":"2014","unstructured":"Padowski JM, Weaver KE, Richards TL, Laurino MY, Samii A, Aylward EH, Conley KE (2014) Neurochemical correlates of caudate atrophy in Huntington's disease. Mov Disord 29: 327\u2013335","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR119","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.expneurol.2005.04.017","volume":"195","author":"B Pan","year":"2005","unstructured":"Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL (2005) Myelin\u2010associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single\u2010 and double\u2010null mice. Exp Neurol 195: 208\u2013217","journal-title":"Exp Neurol"},{"key":"BFEMMM201707763_CR120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/meth.2000.1102","volume":"23","author":"M Parent","year":"2001","unstructured":"Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G (2001) Analysis of amino acids and catecholamines, 5\u2010hydroxytryptamine and their metabolites in brain areas in the rat using in\u00a0vivo microdialysis. Methods 23: 11\u201320","journal-title":"Methods"},{"key":"BFEMMM201707763_CR121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbr.2009.05.022","volume":"203","author":"CM Paul","year":"2009","unstructured":"Paul CM, Magda G, Abel S (2009) Spatial memory: theoretical basis and comparative review on experimental methods in rodents. Behav Brain Res 203: 151\u2013164","journal-title":"Behav Brain Res"},{"key":"BFEMMM201707763_CR122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL (2001a) Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 71: 310\u2013314","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFEMMM201707763_CR123","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.57.4.658","volume":"57","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Zhao H, Stout JC, Brinkman RR, Guttman M, Ross CA, Como P, Manning C, Hayden MR, Shoulson I (2001b) Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 57: 658\u2013662","journal-title":"Neurology"},{"key":"BFEMMM201707763_CR124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington's disease. Biol Psychiatry 59: 57\u201363","journal-title":"Biol Psychiatry"},{"key":"BFEMMM201707763_CR125","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ et\u00a0al (2008) Detection of Huntington's disease decades before diagnosis: the Predict\u2010HD study. J Neurol Neurosurg Psychiatry 79: 874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFEMMM201707763_CR126","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11: 474\u2013483","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BFEMMM201707763_CR127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01276536","volume":"98","author":"SJ Pearson","year":"1994","unstructured":"Pearson SJ, Reynolds GP (1994) Neocortical neurotransmitter markers in Huntington's disease. J Neural Transm Gen Sect 98: 197\u2013207","journal-title":"J Neural Transm Gen Sect"},{"key":"BFEMMM201707763_CR128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","volume":"24","author":"A Petersen","year":"2006","unstructured":"Petersen A, Bjorkqvist M (2006) Hypothalamic\u2010endocrine aspects in Huntington's disease. Eur J Neurosci 24: 961\u2013967","journal-title":"Eur J Neurosci"},{"key":"BFEMMM201707763_CR129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit\u2010Demouliere","year":"2005","unstructured":"Petit\u2010Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177: 245\u2013255","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","volume":"26","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper\u2013Excel\u2010based tool using pair\u2010wise correlations. Biotechnol Lett 26: 509\u2013515","journal-title":"Biotechnol Lett"},{"key":"BFEMMM201707763_CR131","first-page":"135","volume":"8","author":"P Pla","year":"2014","unstructured":"Pla P, Orvoen S, Saudou F, David DJ, Humbert S (2014) Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci 8: 135","journal-title":"Front Behav Neurosci"},{"key":"BFEMMM201707763_CR132","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00433739","volume":"78","author":"A Platel","year":"1982","unstructured":"Platel A, Porsolt RD (1982) Habituation of exploratory activity in mice: a screening test for memory enhancing drugs. Psychopharmacology 78: 346\u2013352","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR133","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","volume":"32","author":"M Politis","year":"2011","unstructured":"Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp 32: 258\u2013270","journal-title":"Hum Brain Mapp"},{"key":"BFEMMM201707763_CR134","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","volume":"584","author":"E Posse de Chaves","year":"2010","unstructured":"Posse de Chaves E, Sipione S (2010) Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett 584: 1748\u20131759","journal-title":"FEBS Lett"},{"key":"BFEMMM201707763_CR135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersen A, Hayden MR (2009) Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132: 919\u2013932","journal-title":"Brain"},{"key":"BFEMMM201707763_CR136","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1098\/rstb.2003.1268","volume":"358","author":"RL Proia","year":"2003","unstructured":"Proia RL (2003) Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 358: 879\u2013883","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFEMMM201707763_CR137","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tips.2008.07.005","volume":"29","author":"A Ramos","year":"2008","unstructured":"Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29: 493\u2013498","journal-title":"Trends Pharmacol Sci"},{"key":"BFEMMM201707763_CR138","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1572-0241.1998.00293.x","volume":"93","author":"SS Rao","year":"1998","unstructured":"Rao SS, Hatfield RA, Suls JM, Chamberlain MJ (1998) Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 93: 985\u2013990","journal-title":"Am J Gastroenterol"},{"key":"BFEMMM201707763_CR139","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","volume":"1370","author":"G Richards","year":"2011","unstructured":"Richards G, Messer J, Waldvogel HJ, Gibbons HM, Dragunow M, Faull RL, Saura J (2011) Up\u2010regulation of the isoenzymes MAO\u2010A and MAO\u2010B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography. Brain Res 1370: 204\u2013214","journal-title":"Brain Res"},{"key":"BFEMMM201707763_CR140","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00429-013-0693-5","volume":"220","author":"JJ Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez JJ, Noristani HN, Verkhratsky A (2015) Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments. Brain Struct Funct 220: 941\u2013953","journal-title":"Brain Struct Funct"},{"key":"BFEMMM201707763_CR141","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington's disease: a clinical review. Orphanet J Rare Dis 5: 40","journal-title":"Orphanet J Rare Dis"},{"key":"BFEMMM201707763_CR142","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","volume":"58","author":"HD Rosas","year":"2002","unstructured":"Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B (2002) Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58: 695\u2013701","journal-title":"Neurology"},{"key":"BFEMMM201707763_CR143","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM (2008) Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 131: 1057\u20131068","journal-title":"Brain"},{"key":"BFEMMM201707763_CR144","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.23762","volume":"26","author":"HD Rosas","year":"2011","unstructured":"Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM (2011) A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov Disord 26: 1691\u20131697","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt","volume":"9","author":"A Rosenblatt","year":"2007","unstructured":"Rosenblatt A (2007) Neuropsychiatry of Huntington's disease. Dialogues Clin Neurosci 9: 191\u2013197","journal-title":"Dialogues Clin Neurosci"},{"key":"BFEMMM201707763_CR146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10: 83\u201398","journal-title":"Lancet Neurol"},{"key":"BFEMMM201707763_CR147","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-61779-313-4_7","volume-title":"Mood and anxiety related phenotypes in mice: characterization using behavioral tests","author":"BA Samuels","year":"2011","unstructured":"Samuels BA, Hen R (2011) Novelty\u2010suppressed feeding in the mouse. In Mood and anxiety related phenotypes in mice: characterization using behavioral tests, Gould TD (ed) pp 107\u2013122. New York: Humana Press"},{"key":"BFEMMM201707763_CR148","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hbm.22612","volume":"36","author":"C Sanchez\u2010Castaneda","year":"2015","unstructured":"Sanchez\u2010Castaneda C, Squitieri F, Di Paola M, Dayan M, Petrollini M, Sabatini U (2015) The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study. Hum Brain Mapp 36: 50\u201366","journal-title":"Hum Brain Mapp"},{"key":"BFEMMM201707763_CR149","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF02245529","volume":"111","author":"O San\u2010Martin\u2010Clark","year":"1993","unstructured":"San\u2010Martin\u2010Clark O, Leza JC, Lizasoain I, Lorenzo P (1993) Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice. Psychopharmacology 111: 233\u2013238","journal-title":"Psychopharmacology"},{"key":"BFEMMM201707763_CR150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O et\u00a0al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805\u2013809","journal-title":"Science"},{"key":"BFEMMM201707763_CR151","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199902000-00006","volume":"58","author":"E Sapp","year":"1999","unstructured":"Sapp E, Penney J, Young A, Aronin N, Vonsattel JP, DiFiglia M (1999) Axonal transport of N\u2010terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58: 165\u2013173","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201707763_CR152","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jnr.490370310","volume":"37","author":"MF Saulino","year":"1994","unstructured":"Saulino MF, Schengrund CL (1994) Differential accumulation of gangliosides by the brains of MPTP\u2010lesioned mice. J Neurosci Res 37: 384\u2013391","journal-title":"J Neurosci Res"},{"key":"BFEMMM201707763_CR153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.02.009","volume":"292","author":"JS Schneider","year":"2010","unstructured":"Schneider JS, Sendek S, Daskalakis C, Cambi F (2010) GM1 ganglioside in Parkinson's disease: results of a five year open study. J Neurol Sci 292: 45\u201351","journal-title":"J Neurol Sci"},{"key":"BFEMMM201707763_CR154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","volume":"324","author":"JS Schneider","year":"2013","unstructured":"Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W (2013) A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients. J Neurol Sci 324: 140\u2013148","journal-title":"J Neurol Sci"},{"key":"BFEMMM201707763_CR155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2015.06.028","volume":"356","author":"JS Schneider","year":"2015","unstructured":"Schneider JS, Cambi F, Gollomp SM, Kuwabara H, Brasic JR, Leiby B, Sendek S, Wong DF (2015) GM1 ganglioside in Parkinson's disease: pilot study of effects on dopamine transporter binding. J Neurol Sci 356: 118\u2013123","journal-title":"J Neurol Sci"},{"key":"BFEMMM201707763_CR156","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14737175.2015.1025383","volume":"15","author":"LC Schwab","year":"2015","unstructured":"Schwab LC, Garas SN, Drouin\u2010Ouellet J, Mason SL, Stott SR, Barker RA (2015) Dopamine and Huntington's disease. Expert Rev Neurother 15: 445\u2013458","journal-title":"Expert Rev Neurother"},{"key":"BFEMMM201707763_CR157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RK, Huston JP (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125: 109\u2013125","journal-title":"Behav Brain Res"},{"key":"BFEMMM201707763_CR158","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hipo.22230","volume":"24","author":"S Sha","year":"2014","unstructured":"Sha S, Zhou L, Yin J, Takamiya K, Furukawa K, Furukawa K, Sokabe M, Chen L (2014) Deficits in cognitive function and hippocampal plasticity in GM2\/GD2 synthase knockout mice. Hippocampus 24: 369\u2013382","journal-title":"Hippocampus"},{"key":"BFEMMM201707763_CR159","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","volume":"96","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96: 7532\u20137537","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201707763_CR160","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","volume":"20","author":"A Silvestroni","year":"2009","unstructured":"Silvestroni A, Faull RL, Strand AD, Moller T (2009) Distinct neuroinflammatory profile in post\u2010mortem human Huntington's disease. NeuroReport 20: 1098\u20131103","journal-title":"NeuroReport"},{"key":"BFEMMM201707763_CR161","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55: 1074\u20131084","journal-title":"Glia"},{"key":"BFEMMM201707763_CR162","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","volume":"159","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Morgan BP, Gasque P (1999) Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol 159: 362\u2013376","journal-title":"Exp Neurol"},{"key":"BFEMMM201707763_CR163","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ et\u00a0al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12: 1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201707763_CR164","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","volume":"24","author":"JS Snowden","year":"2002","unstructured":"Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol 24: 133\u2013145","journal-title":"J Clin Exp Neuropsychol"},{"key":"BFEMMM201707763_CR165","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino S, Mauri L, Chigorno V, Prinetti A (2007) Gangliosides as components of lipid membrane domains. Glycobiology 17: 1R\u201313R","journal-title":"Glycobiology"},{"key":"BFEMMM201707763_CR166","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","volume":"157","author":"J Spampanato","year":"2008","unstructured":"Spampanato J, Gu X, Yang XW, Mody I (2008) Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience 157: 606\u2013620","journal-title":"Neuroscience"},{"key":"BFEMMM201707763_CR167","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","volume":"103","author":"EG Spokes","year":"1980","unstructured":"Spokes EG (1980) Neurochemical alterations in Huntington's chorea: a study of post\u2010mortem brain tissue. Brain 103: 179\u2013210","journal-title":"Brain"},{"key":"BFEMMM201707763_CR168","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","volume":"1762","author":"EC Stack","year":"2006","unstructured":"Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ (2006) Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice. Biochim Biophys Acta 1762: 373\u2013380","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201707763_CR169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR et\u00a0al (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25: 1\u201314","journal-title":"Neuropsychology"},{"key":"BFEMMM201707763_CR170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","volume":"44","author":"P Svenningsson","year":"2004","unstructured":"Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P (2004) DARPP\u201032: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44: 269\u2013296","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFEMMM201707763_CR171","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL et\u00a0al (2011) Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK\u2010HD study: the 12\u2010month longitudinal analysis. Lancet Neurol 10: 31\u201342","journal-title":"Lancet Neurol"},{"key":"BFEMMM201707763_CR172","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL et\u00a0al (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK\u2010HD study: analysis of 24\u00a0month observational data. Lancet Neurol 11: 42\u201353","journal-title":"Lancet Neurol"},{"key":"BFEMMM201707763_CR173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1410.007","volume":"1148","author":"Y Tache","year":"2008","unstructured":"Tache Y, Brunnhuber S (2008) From Hans Selye's discovery of biological stress to the identification of corticotropin\u2010releasing factor signaling pathways: implication in stress\u2010related functional bowel diseases. Ann N Y Acad Sci 1148: 29\u201341","journal-title":"Ann N Y Acad Sci"},{"key":"BFEMMM201707763_CR174","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J","volume":"14","author":"MH Thaut","year":"1999","unstructured":"Thaut MH, Miltner R, Lange HW, Hurt CP, Hoemberg V (1999) Velocity modulation and rhythmic synchronization of gait in Huntington's disease. Mov Disord 14: 808\u2013819","journal-title":"Mov Disord"},{"key":"BFEMMM201707763_CR175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(97)00450-3","volume":"229","author":"TL Thompson","year":"1997","unstructured":"Thompson TL, Moss RL (1997) Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett 229: 145\u2013148","journal-title":"Neurosci Lett"},{"key":"BFEMMM201707763_CR176","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, Martinez\u2010Vincente M, Arrasate M, O'Rourke JG, Khashwji H et\u00a0al (2009) IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 187: 1083\u20131099","journal-title":"J Cell Biol"},{"key":"BFEMMM201707763_CR177","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3171\/2012.5.JNS112224","volume":"117","author":"RC Turner","year":"2012","unstructured":"Turner RC, Seminerio MJ, Naser ZJ, Ford JN, Martin SJ, Matsumoto RR, Rosen CL, Huber JD (2012) Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease. J Neurosurg 117: 629\u2013637","journal-title":"J Neurosurg"},{"key":"BFEMMM201707763_CR178","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.pnpbp.2004.05.005","volume":"28","author":"RE Ulloa","year":"2004","unstructured":"Ulloa RE, Nicolini H, Fernandez\u2010Guasti A (2004) Sex differences on spontaneous alternation in prepubertal rats: implications for an animal model of obsessive\u2010compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 28: 687\u2013692","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFEMMM201707763_CR179","doi-asserted-by":"crossref","first-page":"e75720","DOI":"10.1371\/journal.pone.0075720","volume":"8","author":"K Vajn","year":"2013","unstructured":"Vajn K, Viljetic B, Degmecic IV, Schnaar RL, Heffer M (2013) Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS One 8: e75720","journal-title":"PLoS One"},{"key":"BFEMMM201707763_CR180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2202-11-92","volume":"11","author":"C Vandeputte","year":"2010","unstructured":"Vandeputte C, Taymans JM, Casteels C, Coun F, Ni Y, Van Laere K, Baekelandt V (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11: 92","journal-title":"BMC Neurosci"},{"key":"BFEMMM201707763_CR181","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cge.12628","volume":"89","author":"T Vinther\u2010Jensen","year":"2015","unstructured":"Vinther\u2010Jensen T, Nielsen TT, Budtz\u2010Jorgensen E, Larsen IU, Hansen MM, Hasholt L, Hjermind LE, Nielsen JE, Norremolle A (2015) Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes. Clin Genet 89: 320\u2013327","journal-title":"Clin Genet"},{"key":"BFEMMM201707763_CR182","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington's disease \u2013 neuropathology. Handb Clin Neurol 100: 83\u2013100","journal-title":"Handb Clin Neurol"},{"key":"BFEMMM201707763_CR183","doi-asserted-by":"crossref","first-page":"13790","DOI":"10.1523\/JNEUROSCI.2275-14.2014","volume":"34","author":"J Wang","year":"2014","unstructured":"Wang J, Cheng A, Wakade C, Yu RK (2014) Ganglioside GD3 is required for neurogenesis and long\u2010term maintenance of neural stem cells in the postnatal mouse brain. J Neurosci 34: 13790\u201313800","journal-title":"J Neurosci"},{"key":"BFEMMM201707763_CR184","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0076-6879(99)09026-6","volume":"309","author":"EE Wanker","year":"1999","unstructured":"Wanker EE, Scherzinger E, Heiser V, Sittler A, Eickhoff H, Lehrach H (1999) Membrane filter assay for detection of amyloid\u2010like polyglutamine\u2010containing protein aggregates. Methods Enzymol 309: 375\u2013386","journal-title":"Methods Enzymol"},{"key":"BFEMMM201707763_CR185","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1083\/jcb.112.6.1205","volume":"112","author":"DE Weinstein","year":"1991","unstructured":"Weinstein DE, Shelanski ML, Liem RK (1991) Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112: 1205\u20131213","journal-title":"J Cell Biol"},{"key":"BFEMMM201707763_CR186","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01688638708405354","volume":"9","author":"RS Wilson","year":"1987","unstructured":"Wilson RS, Como PG, Garron DC, Klawans HL, Barr A, Klawans D (1987) Memory failure in Huntington's disease. J Clin Exp Neuropsychol 9: 147\u2013154","journal-title":"J Clin Exp Neuropsychol"},{"key":"BFEMMM201707763_CR187","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2008.05.017","volume":"213","author":"RC Wolf","year":"2008","unstructured":"Wolf RC, Sambataro F, Vasic N, Schonfeldt\u2010Lecuona C, Ecker D, Landwehrmeyer B (2008) Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol 213: 137\u2013144","journal-title":"Exp Neurol"},{"key":"BFEMMM201707763_CR188","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0091-3057(91)90559-K","volume":"40","author":"E Yadin","year":"1991","unstructured":"Yadin E, Friedman E, Bridger WH (1991) Spontaneous alternation behavior: an animal model for obsessive\u2010compulsive disorder? Pharmacol Biochem Behav 40: 311\u2013315","journal-title":"Pharmacol Biochem Behav"},{"key":"BFEMMM201707763_CR189","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00964984","volume":"5","author":"JR Yandrasitz","year":"1980","unstructured":"Yandrasitz JR, Cohn RM, Masley B, DelRowe D (1980) Evaluation of the binding of serotonin by isolated CNS acidic lipids. Neurochem Res 5: 465\u2013477","journal-title":"Neurochem Res"},{"key":"BFEMMM201707763_CR190","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","volume":"93","author":"LJ Yang","year":"1996","unstructured":"Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) Gangliosides are neuronal ligands for myelin\u2010associated glycoprotein. Proc Natl Acad Sci USA 93: 814\u2013818","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201707763_CR191","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1471-4159.2002.01084.x","volume":"82","author":"IG Yohrling","year":"2002","unstructured":"Yohrling IG, Jiang GC, DeJohn MM, Robertson DJ, Vrana KE, Cha JH (2002) Inhibition of tryptophan hydroxylase activity and decreased 5\u2010HT1A receptor binding in a mouse model of Huntington's disease. J Neurochem 82: 1416\u20131423","journal-title":"J Neurochem"},{"key":"BFEMMM201707763_CR192","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s007020070084","volume":"107","author":"L Yu","year":"2000","unstructured":"Yu L, Liao PC (2000) Sexual differences and estrous cycle in methamphetamine\u2010induced dopamine and serotonin depletions in the striatum of mice. J Neural Transm 107: 419\u2013427","journal-title":"J Neural Transm"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201707763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201707763","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201707763\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201707763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201707763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:22:36Z","timestamp":1779085356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201707763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":192,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11,1]]}},"alternative-id":["BFEMMM201707763"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201707763","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]},"assertion":[{"value":"1 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SS holds a non\u2010provisional US patent for the use of GM1 in treating HD. SS and the other authors declare no other financial interests or potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}